Close

PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference Sep 20, 2023 04:05PM
PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference Sep 22, 2022 08:00AM
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases Mar 10, 2022 05:45AM
Johnson & Johnson (JNJ), Cidara Therapeutics (CDTX), Pfizer (PFE), and PDS Biotechnology (PDSB) - Cantor Fitzgerald's Top Flu Vaccine Candidates for 2022 Feb 17, 2022 05:55AM
PDS Biotechnology to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference Sep 22, 2021 08:30AM


Jun 28, 2021 06:02AM Cantor Fitzgerald Starts PDS Biotechnology Corp (PDSB) at Overweight
Jun 17, 2021 04:15PM PDS Biotechnology Corporation Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
Jun 15, 2021 09:00AM PDS Biotech Prices Public Offering of Common Stock
Jun 14, 2021 04:02PM PDS Biotechnology (PDSB) Announces Proposed Offering of Common Stock
Jun 14, 2021 04:02PM PDS Biotech Announces Proposed Offering of Common Stock